Search Results

Piragliatin 5mg 5mg  | Purity Not Available

Adooq Bioscience

Piragliatin is a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus

More Information Supplier Page

Piragliatin 25mg 25mg  | Purity Not Available

Adooq Bioscience

Piragliatin is a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus

More Information Supplier Page

Piragliatin 10mg 10mg  | Purity Not Available

Adooq Bioscience

Piragliatin is a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus

More Information Supplier Page

Brexpiprazole 5mg 5mg  | Purity Not Available

Adooq Bioscience

Brexpiprazole is a novel D2 dopamine partial agonist investigational product currently in clinical trials for the treatment of depression, schizophrenia, and attention deficit hyperactivity disorder (ADHD).

More Information Supplier Page

Brexpiprazole 25mg 25mg  | Purity Not Available

Adooq Bioscience

Brexpiprazole is a novel D2 dopamine partial agonist investigational product currently in clinical trials for the treatment of depression, schizophrenia, and attention deficit hyperactivity disorder (ADHD).

More Information Supplier Page

ONT-093 10mg 10mg  | Purity Not Available

Adooq Bioscience

ONT-093 is an orally bioavailable P-glycoprotein pump inhibitor, for the potential reversal of multidrug resistance in patients undergoing cancer chemotherapy.

More Information Supplier Page

ONT-093 25mg 25mg  | Purity Not Available

Adooq Bioscience

ONT-093 is an orally bioavailable P-glycoprotein pump inhibitor, for the potential reversal of multidrug resistance in patients undergoing cancer chemotherapy.

More Information Supplier Page